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Abstract
BACKGROUND: The extracorporeal shock wave lithotripsy (ESWL) is a non-invasive method in the treatment of 
urinary tract stones and its discovery has led to a complete change in the therapeutic strategy for urolithiasis. Due to 
the low morbidity and excellent fragmentation of the stones, ESWL has proven to be an effective and non-invasive 
method in the treatment of renal stones.
AIM: The aim of this retrospective study is to evaluate the efficacy and safety of the ESWL as a monotherapy in the 
treatment of moderate size kidney stones with stone area (SA) of 100–300 mm².
MATERIALS AND METHODS: We made a retrospective study of 98 patients with moderate size kidney stones with 
SA of 100–300 mm², divided into two subgroups, into a group with a SA of 100–200 mm² and with 200–300 mm², 
treated with ESWL in the period of November 2018–December 2019. The patients were treated with a third-
generation electromagnetic lithotripter (Lithoskop®, Siemens Medical Systems, Erlangen, Germany), with a source 
of electromagnetic shocks (Pulso™) and dual ultrasonographic/fluoroscopic system for detection of the stones. The 
stone location, size, maximum energy used, localization technique, number of shock waves, sessions, re-treatment 
rate, and additional procedures were reviewed. All the patients before the intervention had a complete laboratory and 
radiological examinations. Postoperatively, patients were monitored on the 1st, 30th, and 90th post-operative days.
RESULTS: Ninety-eight patients with solitary kidney stone with a SA of 100–300 mm² were treated with ESWL. The 
study included 58 men (59.18%) and 44 women (40.81%). The average length and width of the stone were 15.47 
± 2.68 mm and 12.99 ± 2.83 mm, respectively. The average surface area of the stones in our series was 203.78 ± 
72.85 mm². The mean number of treatments for the entire series of patients was 1.82 ± 0.91. The mean number of 
shock waves for the total series of patients was 3899.11 ± 40. The mean energy used for the overall patient series 
was 110106.17 ± 21489.61 mJ. The total re-treatment rate was 47.95%. The entire rate of additional procedures was 
19.38%. The overall success rate (SR) in our study was 77.55%. The efficiency quotient for the upper-middle and 
lower calyx was 55.57, 57.15, and 30.81, respectively.
CONCLUSION: ESWL is a safe and effective method in the treatment of renal stones, and we recommend as the first 
method in the treatment of moderate size kidney stone with a surface area of 100–300 mm². The treatment of each 
patient should be individualized and take into account all favored and non-favored factors that influence the decision 
to choose extracorporeal lithotripsy as a method of treatment of medium-sized stones.
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Introduction
Urolithiasis is one of the most common 
diseases of modern society. The incidence and 
prevalence of renal stones are increasing as a result of 
changes in diet and lifestyle habits under the influence 
of Western countries. Nephrolithiasis is one of the most 
common causes of morbidity and deterioration in the 
quality of life, with a prevalence of 5–10%. In addition, 
nephrolithiasis is recurrent disease and the risk of 
recurrence is about 50% in the first 10 years and 80% 
in 20 years [1]. Therefore, nephrolithiasis has a strong 
impact on the quality of life and socioeconomic factors.
In the era of modern medicine, urolithiasis 
continues to be one of the major diseases in the daily 
practice of urologists. An important step in the past 
three decades that drastically changed the approach 
of modern urology in the treatment of stone disease 
of the urinary tract (UT) was the introduction of 
extracorporeal shock wave lithotripsy (ESWL) for the 
treatment of kidney stones in 1980, when the Dornier 
prototype lithotripter human model 1 (or HM1), was 
introduced [2]. The original unmodified HM3, classified 
as a first-generation lithotripter, although no longer in 
use today, is still considered a reference standard due 
to its superiority and reliability [3]. To increase patient 
comfort and safety, second- and third-generation 
lithotripters were subsequently developed with various 
shock wave principles such as electrohydraulic, 
electromagnetic, and piezoelectric. Unlike HM3, where 
the intervention was performed in a water bath with 
spinal or general anesthesia, in the second-generation 
and third-generation lithotripters, the procedure is 
performed with sedoanalgesia. The introduction of 
modern imaging techniques in these lithotripters is 
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another huge step forward in the performance of this 
method. The main goal of the new lithotripters is to 
increase the effectiveness of the breaking up of the 
stones, to reduce the pain during the intervention and to 
minimize the possibility of tissue injury. Due to the low 
morbidity and excellent fragmentation of the stones, 
ESWL has proven to be an effective and non-invasive 
method in the treatment of nephrolithiasis [4].
Objective
The objective of this retrospective study is to 
evaluate the effectiveness and safety of the ESWL as a 
monotherapy in the treatment of moderate size kidney 
stones with a stone area (SA) of 100–300 mm², with the 
determination of the success rate – SR, the re-treatment 
rate, need for additional procedures, the efficiency 
quotient (EQ), and complications after the treatment.
Materials and Methods
We made a retrospective study of 98 patients 
with moderate size kidney stones of 100–300 mm², 
divided into two subgroups, into a group with stone size 
expressed as surface area (SA) of 100–200 mm² and with 
200–300 mm², treated with ESWL using a third-generation 
electromagnetic lithotripter that has improved technical 
performance with a wide focus and deep penetration of the 
shock wave, in the period of November 2018–December 
2019, (Lithoskop®, Siemens Medical Systems, Erlangen, 
Germany, with a source of electromagnetic shock waves 
-Pulso™, with a focal length of 160 mm and a beam width 
of up to 12 mm; using this focal size, the focal density of 
the energy could be reduced, thus avoiding injury to the 
surrounding tissue). All the patients before the intervention 
had complete examinations: medical history with a 
physical exam, complete blood analysis (hemogram, 
serum values of urea, creatinine, sodium, potassium, 
uric acid, albumin, and proteins) urine sedimentation 
rate, hemostasis tests and blood group, urine culture, 
electrocardiogram (12 leads), X-ray image of the heart 
and lungs, and consultation with an anesthesiologist. The 
degree of anesthesia risk was determined by the scale of 
the American Society of Anesthesiologists.
Exclusion criteria were obesity >100 kg 
(because of the technical limitation of the extracorporeal 
lithotriptor device), staghorn stones, stones smaller than 
100 mm² and stones larger than 300 mm², untreated 
infection of the UT, congenital anomalies (obstruction 
of ureteropelvic or ureterovesical juncture), solitary 
kidney, presence of uncorrected coagulopathies, 
bilateral upper UT obstruction, patients with radiolucent 
stones, and pregnant women.
Before every intervention, an ultrasonographic 
examination of the UT and computerized tomography 
(CT) urography was performed to determine the size of 
the stones, the anatomical characteristics of the kidney, 
and its function. The size of the stones was calculated 
based on the widest perpendicular diameters of CT 
urography series marked as length and width. The 
surface of the stones was determined by multiplying the 
two widest perpendicular diameters.
With patients taking aspirin or other 
anticoagulants, the same was discontinued 5–7 days 
before the treatment. All patients undertook bowel 
preparation with Bisacodyl (Dulcolax) 10 mg individual 
oral dose and were advised to discontinue the intake 
of any food the night before treatment. Patients with a 
bacterial infection detected by urine culture were treated 
with antibiotic therapy and treated on after receiving 
sterile urine culture.
The patients were treated with a third-
generation electromagnetic lithotripter (Lithoskop®, 
Siemens Medical Systems, Erlangen, Germany), with 
a source of electromagnetic shocks (Pulso ™) and 
dual ultrasonographic/fluoroscopic system for detection 
of the stones, that has two components: An isocentric 
C-arm with X-rays to perform real-time fluoroscopy and 
an X-ray if needed and an inbuilt rotating ultrasound 
head that can be inserted in the coupling system. The 
entire focus length of the lithotripter is 160 mm, the focal 
width at −6 dB is 8–12 mm (depending on the set power 
parameters) and is in correlation with the maximum 
pressure of 8–75 MP. The large focus of this lithotripter 
allows high absolute with low-density energy doses to 
reduce side effects, including tissue injury.
To immobilize the patient and to reduce the 
movement of the stone due to respiration, we routinely 
used a compression belt fixed over the patient’s 
abdomen. The patient was treated in a supine position 
and the X-ray and fluoroscopy were used to detect the 
stone. The intensity of the shock wave started from 
0.1 mJ and gradually was increased to 4 mJ according 
to the manufacturer’s recommendations. The mean and 
maximum energy levels during treatment automatically 
appeared on display after the completion of the 
intervention. The frequency of shock waves for the 
kidney stones was 90/min, energy intensity from 0.1 mJ 
to 4 mJ with a maximum number of shock waves to 
4000. Blood pressure (BP) was controlled alternatively 
every 5 min. Continuous pulse oximetry was used for 
each treatment. Ureteral stents before the procedure 
were placed only in patients with upper UT obstruction 
to prevent deterioration of renal function.
A maximum of three SWL treatments was done 
in patients with unsuccessful complete disintegration 
of the stone after the first treatment. Unsuccessful 
fragmentation or presence of residual fragments >4 mm 
after three treatments were considered a failed 
treatment and an additional alternative minimal invasion 
treatment was recommended to the patient. The 
additional measures after the treatment were defined 
as measures for the active removal of the stone with 
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ureteroscopy or percutaneous nephrolithotomy (PCNL) 
when symptomatic residual fragments were present 
as well as any post-operative intervention after SWL. 
Intravenous sedoanalgesia was used in each patient 
using Amp Fentanyl, that is, (1 mg/kg, dose) and Amp 
Midazolam, that is, (0.05–0.1 mg/kg dose). The dose 
was adjusted according to the reported level of pain. 
The patient was monitored during the procedure by 
checking the vital signs: Pulse heart rate, respiration 
rate, BP, and oxygen saturation (pulse oximetry). On 
the same day, the patient was discharged from the 
hospital with a recommendation for oral medication for 
analgesia and alpha-blocker.
Postoperatively patients were monitored 
according to the following protocol: On the 1st day 
after the procedure, a complete blood count and 
ultrasonography of the UT were performed, after 
1-month ultrasonography of the UT and a Kidney-
Ureter-Bladder X-ray was done and after 3 months, 
ultrasonography of the UT and non-contrast CT. We 
also evaluated the outcome by calculating the EQ 
defined by the formula: Stone free rate (SFR) × 100/
(100 + rate of re-treatment in percentage + rate of 
additional measures in percentage).
We defined the successfulness of the treatment 
by determining the success rate (SR), the re-treatment 
rate, the need for additional procedures, the EQ, 
and complications after treatment. The treatment of 
patients with clinically insignificant residual fragments 
(CIRF) <4 mm and those who were stone-free after 
3 months was considered a successful treatment. 
Unsuccessful fragmentation or presence of residual 
fragments >4 mm after 3 treatments were considered 
a failure of the treatment and an alternative minimally 
invasive treatment was recommended to the patient.
The effectiveness of the method was assessed 
by determining the absence of residual fragments 
of the stone or the presence of clinically insignificant 
fragments <4 mm on the control X-ray examinations 
on the 1st, 30th, and 90th post-operative day. The time 
of the intervention was measured from the moment of 
the beginning of the lithotripsy until the ending of the 
treatment. The safety of the method was determined 
in relation to the frequency and severity of the 
complications during and after the procedure. The 
criterion for post-operative fever was the increase of 
body temperature (BT) >38.5°C in the post-operative 
period without the presence of diagnostic criteria for 
sepsis. The complications were classified according to 
the modified scale of Clavien-Dindo.
Statistical analysis
Statistical for Windows 7.0 and SPSS 14.0. 
were used for statistical analysis in the study. The 
numerical variables were presented as average values 
and standard deviations and for the comparison of two 
numerical values, the Student’s t-test was used if the 
distribution of the values was parametric or the Mann–
Whitney U test if the distribution of values was non-
parametric. For the attributive variables, proportions 
were used. For the comparison of two attributive 
variables X2 test and Fisher’s exact p-test to determine 
the level of significance were used. For the correlation 
of two numerical variables, the Spearman’s Rank test 
for correlation was used. p < 0.05 was considered 
statistically significant.
Results
Ninety-eight patients with solitary kidney stone 
with a surface area of 100–300 mm² were treated 
with ESWL. In 51 patients (52.04%), the stone was 
100–200 mm² in size, and in 47 patients (47.95%), the 
stone was 200–300 mm² in size. The study included 
58 men (59.18%) and 44 women (40.81%). The mean 
age of patients in this series was 48.79 ± 10.25 years. In 
54 (55.10%) patients, the stone was localized in the right 
kidney, and in 44 (44.89%) patients in the left kidney. 
The average length and width of the stone were 15.47 ± 
2.68 mm and 12.99 ± 2.83 mm, respectively. The average 
surface area of the stones in our series was 203.78 
± 72.85 mm². The stones were localized in the upper, 
middle, and lower calyx in 29 (29.59%), 37 (37.75%), 
and 32 (32.65%) patients, respectively. In three of the 
treated patients (3.06%), there was a previous surgical 
intervention at the ipsilateral kidney and in 9 (9.18%) a 
DJ probe was placed (Tables 1 and 2).
Table 1: Pre-operative characteristics of patients
Parameters Upper calyx
n=29
Middle calyx
n=37
Lower calyx
n=32
Total
n=98
Gender (number/%)
Men 17 21 20 58 (59.18)
Women 12 16 12 40 (40.81)
Side (number/%)
Right kidney 17 20 17 54 (55.10)
Left kidney 12 17 15 44 (44.89)
Previous procedures (number/%)
Pyelolithotomy 2 1 0 3 (3.06)
PCNL 0 0 0 0
DJ 2 4 3 9 (9.18)
Pre-operative anesthesiology risk according to ASA (number/%)
ASA 1 class 17 12 5 34 (34.69)
ASA 2 class 18 17 11 46 (46.93)
ASA 3 class 7 5 6 18 (18.36)
ASA: American Society of Anesthesiologists, PCNL: Percutaneous nephrolithotomy.
The mean number of treatments for the entire 
series of patients was 1.82 ± 0.91, while the mean 
Table 2: Pre-operative characteristics of the stone
Medium length of the stone (mm ± SD) 15.47 ± 2.68
Medium width of the stone (mm ± SD) 12.99 ± 2.83
Stone surface area (mm² ± SD) 203.78 ± 72.85
Features of the stone (n/%)
Solitary stones 98 (100)
Multiple stones 0
Localization of the stone (n/%)
Upper calyx 29 (29.59)
Middle calyx 37 (37.75)
Lower calyx 32 (32.65)
Number of patients by stone size (mm²)
100–200 mm² 51 (52.04)
200–300 mm² 47 (47.95)
number of shock waves was 3899.11 ± 40. 91 Overall, 
a statistically significant difference in both cases was 
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determined only in relation to the size (p = 0.000 
and p = 0.023, respectively), but not in relation to 
the localization of the stones. The total number of 
treatments and the total number of shock waves 
required for complete clearance of the stone correlated 
with its maximum diameter (p = 0.000 and p = 0.023, 
respectively).
The mean energy used for the overall patient 
series was 110106.17 ± 21489.61 mJ. The mean 
energy used for the upper, middle, and lower caliceal 
stones showed a borderline statistical significance 
(p = 0.049). Regarding stone size, there was not any 
significant difference in the energy used (p = 0.898). The 
results showed that there was a statistically significant 
difference only between the upper and lower calyces in 
the applied energy (p = 0.04) (Table 3).
The total re-treatment rate was 47.95%. The 
re-treatment rate for stones between upper and lower 
calyces was statistically significant (p = 0.007), as well 
as regarding stone size (p = 0.002) (Tables 3 and 4).
Table 4: Characteristics of the treatment according to stone 
burden
Parameters 10–15 мм
n=51
16–20 мм
n=47
Total
n=98
Mean number of session (range) 1.51 2.15 1.82 (1–3)
Mean number of SW (Mean ± SD) 3814.24 3991.17 3899.11
Mean energy (mJ ± SD) 109839.18 ± 
22640.25
110395.89 ± 
20407.95
110106.17 ± 
21489.53
Re-treatment rate % 31.37 65.95 47.95
Auxiliary procedure % 9.80 29.78 19.38
Treatment success % 88.3 66.0 77.55
EQ 62.54 33.71 46.31
The entire rate of additional procedures 
was 19.38%. A statistically significant difference 
was determined between the upper and lower calyx 
(p = 0.000) and also regarding stone size (p = 0.014). 
Regarding the additional procedures, in 4.1% of 
the patients, a DJ probe was placed, in 3.1% a 
ureterorenoscopy with lithotripsy of migrating stones 
in the distal ureter was made and 12.2% of patients 
were treated with percutaneous nephrolithotripsy due 
to SWL failure. The EQ for the upper, middle, and 
lower calyx was 55.57, 57.15, ad 30.81, respectively 
(Tables 3 and 4).
The overall SR in our study was 77.55%. SFR 
after 3 months of treatment was 72.4% for upper calyx, 
75.7% for middle calyx, and 56.7% for lower calyx, while 
CRIF <4mm were found in 10.3%, 10.8%, and 6.3% in 
the upper, middle, and lower calyx, respectively. SFR 
for stones of 100–200 mm² was 82.4% and for stones 
of 200-300 mm² was 57.2%, while CIRF <4 mm were 
found in 5.9% of the stones of 100–200 mm², and in 
12.8% of the stones of 200–300 mm². The SR for the 
Table 3: Characteristics of the treatment according to location
Parameters Upper calix n=29 Middle calix n=37 Lower calix n=32 Total n=98
Mean number of session (range) 1.59 1.59 2.28 1.82 (1–3)
Mean number of SW (M ±SD) 3879.10 3958.14 3849.11 3899.11
Mean energy (mJ ± SD) 104381.00 ± 28334.95 108305 ± 21456.40 117376.97 ± 9802.53 110106.17 ± 21489.53
Re-treatment rate % 37.93 35.13 71.87 47.95
Auxiliary procedure % 10.34 16.21 31.25 19.38
Treatment success % 82.4 86.5 62.6 77.55
EQ 55.57 57.15 30.81 46.31
upper, middle, and lower calyceal stones was 82.4%, 
86.5%, and 62.6%, respectively. The SR for the stone 
100–200 mm in size was 88.3% and for the stone 
200–300 mm in size was 66.0%.
A statistically significant difference also was 
established between the stone size and SR (p = 0.008) 
(Table 5).
Table 5: Success rate in relation to localization and the stone 
burden
Parameters SFR % CIRF % Success rate % Failure % Total %
Stone localization
Upper calix n=29 72.4 10.3 82.4 17.2 100
Middle calix n=37 75.7 10.8 86.5 13.5 100
Lower calix n=32 56.7 6.3 62.6 37.5 100
Total 68.4 9.2 77.55 22.4 100
Stone burden
100–200 мм² n=51 82.4 5.9 88.3 11.8 100
200–300мм² n=47 53.2 12.8 66.0 34.0 100
Total 68.4 9.2 77.55 22.4 100
Most of the complications were minor: 
Dysuria 7.1%, UTI 1.02%, elevated BT 1.02%, pain 
with admission to the hospital 3.06%, and stone path 
(steinstrasse) 5.1% (Table 6).
Table 6: Complications
Type of complications n (%) Clavien-Dindo grade
Intraoperative / /
Post-operative
Dysuria 7 (7.10) I
UTI 1 (1.02) II
Febrility >38.5°C 1 (1.02) I
Pain and admission 3 (3.06) I
Stone path (steinstrasse) 5 (5.1) IIIb
Treatment of complications
Medical therapy 12 (21.42)
Medical therapy + JJ stent 0
URS 3 (3.06)
URS: Ureteroscopy.
Discussion
The ESWL is a non-invasive method in the 
treatment of UT stones and its discovery has led to 
a complete change in the therapeutic strategy for 
urolithiasis. Immediately after its introduction, ESWL was 
a widely accepted method worldwide, and today a large 
percentage of upper UT stones are successfully treated 
with this method. As a result of this significant progress and 
good results evident in clinical practice in the treatment of 
urolithiasis, the American Urological Association and the 
European Association of Urology (EAU) have published 
guidelines for the treatment of renal stones, according to 
the size and location of the stones [5].
However, certain issues remain controversial, 
including the choice of treatment for medium-sized renal 
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stones. In the EAU guide, percutaneous nephrolithotripsy 
is recommended as a method of choice for kidney 
stones larger than 20 mm, while ESWL for kidney stones 
<10 mm. Furthermore, ESWL, retrograde intrarenal 
surgery, and PCNL are recommended as methods 
of choice in the treatment of renal calculi between 10 
and 20 mm. Which minimally invasive technique will be 
chosen depends on several factors such as the size, 
number, and location of the stones, chemical composition, 
degree of upper UT obstruction, associated anatomical 
abnormalities, patient comorbidities, adequate 
equipment, and operator experience [6], [7]. ESWL is 
a preferred method in many clinical centers due to its 
low invasiveness, lower complication rate, and method 
effectiveness. In the last two decades, the emphasis 
has been on the development of electromagnetic 
shock wave lithotripters, which are more durable, with 
variations in the size of the focus zone and are aimed 
at improving the safety and efficacy of treatment [8], [9].
In this retrospective study, we present the 
results of the treatment of renal stones from 100 to 
300 mm² with SWL performed using a third-generation 
lithotripter (Lithoskop®, Siemens Medical Systems, 
Erlangen, Germany) [10].
In our study, the overall SR at the end of the 
3rd month was 77.55%, which is in line with the results 
published by Saxby et al. [11], where the total SFR is 
75%. The total SR for upper and middle calyces was 
84.6%. These results are consistent with the results 
of most published studies such as that of Cecen 
et al. which establish an SWL efficiency of 87% in the 
treatment of stones in the upper and middle calyces 
with a size of 10–20 mm [12].
In a review of 3278 patients where SWL 
treatment was performed with Lithostar lithotripter, SFR 
after 3 months for upper, middle, and lower calyces was 
82%, 71%, and 48%, respectively [13]. Similar results 
were presented in the study of Graff et al. [14], with 
SFR of 78%, 76%, and 58% for renal stones in the 
upper, middle, and lower calyces in 1003 patients. In 
this study, the probability for a successful outcome was 
lower proportionately with the increase of the size of the 
stones. In the study of Öbek et al. [15], the entire SFR 
for calculi of 1.1–2 cm was 70%, 73%, and 57% for the 
upper, middle, and lower calyx, respectively.
The results of our research are consistent 
with these results. Furthermore, in our study, the 
likelihood of treatment success was reduced directly 
proportionally to the increase of the stone burden. The 
small differences in SR after SWL for upper and middle 
caliceal stones are probably due to several factors, 
including the use of different types of lithotripters, the 
operator’s experience, and small differences in the 
mean surface area of the stones in different studies.
The localization of the stones in the lower 
group of calyces is an important limiting factor for the 
effectiveness of SWL due to the difficult elimination of 
fragments. Infundibulopelvic angle <70, infundibulum 
length >5 mm, and infundibulum width <5 mm are 
a poor prognostic factor in SWL for lower caliceal 
stones.
The treatment of lower caliceal stones with 
SWL still remains a controversial question. According 
to most studies, lower caliceal stones have a lower rate 
of efficacy after monotherapy with SWL than the stones 
in the middle and upper group of calyces [16].
In a meta-analysis of 13 published studies 
by Lingeman et al. [17] for the treatment of lower pole 
stones with SWL, SFR ranged between 25% and 
85%. The total SFR in this analysis was 60%, which 
is identical to ours. According to the results stratified 
by stone size, SFR for stones smaller than 10 mm, 
from 10 to 20 mm, and >20 mm was 74%, 56%, and 
33%, respectively. Netto et al. [18] reported an SFR of 
79% for stones in the lower pole. SFR was 78%, 85%, 
and 50% for stones of 10 mm, 11–20 mm, and 20 mm, 
respectively. Rao et al. [19] in a prospective study of 
257 patients for 10–20 mm stones presented a 69.3% 
SR at the end of 12 weeks while You et al. [20] showed 
an SFR of 63.6% at the end of 12 weeks for the same 
size of stones. The prospective study of Anup et al. 
[21] included radiolucent stones with a stone size of 
10–20 mm located in the lower pole. The SFR in their 
study after 3 months was 73.8%, with a re-treatment 
rate of 63.4% and rate of additional procedures of 
22.2%.
In our study, the overall SR for lower pole 
stones from 100 to 300 mm² was 62.6% after 3 months 
of treatment. These results are consistent with the 
results of several published studies such as those of 
Rao et al. and You et al., including the results published 
in the meta-analysis of Lingeman et al.
The low rate of re-treatment in patients treated 
with Dornier HM3 (5–14%) can only be achieved if 
the procedure is performed under general or spinal 
anesthesia. In new lithotripsies, the procedure is 
performed with intravenous sedoanalgesia and the 
re-treatment rate ranges from 20% to 30% [22]. In the 
study of Bierkens et al., second-generation lithotripters 
have a higher re-treatment rate in comparison of the first 
generation lithotripters 30% compared with 10% [22] 
Netto et al. [18] in their study show a total re-treatment 
rate of 42%.
The overall re-treatment rate in the entire patient 
series in our study with a third-generation lithotripter was 
47.95%, which is consistent with the results of Netto 
et al. [18]. The re-treatment rate was largely limited to 
the second treatment, with a median number of session 
per patient of 1.82. The higher re-treatment rate was 
probably due to several factors such as the treatment of 
patients in sedoanalgesia which limited the application 
of high energy shock waves due to pain, but also to the 
fact of early second treatment which in our series was 
after 3 weeks to achieve higher SFR.
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In our study, the total rate in additional 
procedures was 19.38%, similar to the study of 
Kumar et al. [21], where the entire rate of additional 
procedures was 20.2%. Of the additional procedures in 
4.1% of patients, a DJ probe was placed, at 3.1%, a 
ureterorenoscopy with lithotripsy of migrating stones in 
the distal ureter was performed, and 12.2% of patients 
were treated with percutaneous nephrolithotripsy due to 
SWL failure.
To compare the performance of different 
types of lithotripters, the concept of the quotient 
of efficiency (EQ) was introduced, which is a more 
objective parameter in the evaluation of the results 
because it takes into account not only SFR but also 
the rate of re-treatment and additional procedures in 
determining the efficiency of the method when using 
different lithotripters. However, we should keep in 
mind that neither the percentage of residual stones 
nor the degree of complications is included here, so 
we should always be careful in comparing different 
EQs [8].
We also calculated the coefficient of efficiency 
(EQ) per calix, which in our study of the upper-middle 
and -lower calyces was 55.5, 57.1, and 30.8.
Complications after SWL are usually minimal 
and are associated with the formation and removal 
of fragments, effects on the kidney and surrounding 
tissues, effects on renal function, and post-treatment 
infections. Each of these complications can be 
prevented by following appropriate measures such as: 
Recognizing the limitations and contraindications to 
this method, recognizing and treating accompanying 
comorbidities in patients, treating UT infections, 
personalizing treatment, and improving performance 
and safety in the use of SWL [23].
In our study, none of the cases had a 
complication of Grade IV or V according to the modified 
Clavien-Dindo scale. Post-operative complications 
were classified according to the Clavien-Dindo scale 
I, II, and III. The overall complication rate was 17.3% 
where Grade I was 11.22%, Grade II was 1.02, and 
Grade IIIb was 5.1%, which is consistent with most 
studies, including the study of Bas et al. [24] and Turna 
et al. [25]. No significant intraoperative complications 
were observed in this study and all procedures were 
performed until the end of treatment.
Most of the 12 patients had conservative drug 
treatment with analgesic and antipyretic therapy. In one 
patient, oral antibiotic therapy was included, second-
generation cephalosporin, according to an antibiogram. 
Out of five patients with steinstrasse, three patients 
underwent surgery, ureterorenoscopy, for the breakup 
of the stones migrating in the distal ureter.
The retrospective character of the study and 
the lack of data on the chemical composition of the 
stones are the major limiting factors in this study.
Conclusion
Our experience with the third generation of 
extracorporeal electromagnetic lithotripter showed that 
new generations of lithotripters are safe and effective in 
the treatment of renal stones. The overall SR in our study 
was 77.5%. Therefore, we recommend ESWL as the 
first method in the treatment of a moderate size stone of 
100–300 mm². However, the probability of a successful 
outcome was lower in correlation with the larger stone 
size. Therefore, the treatment of each patient should be 
individualized and all favored and non-favored factors 
that influence the decision to choose extracorporeal 
lithotripsy as a method of treatment of medium-sized 
stones should be taken into account.
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